联盛化学
(301212)
| 流通市值：24.44亿 | | | 总市值：28.16亿 |
| 流通股本：9375.00万 | | | 总股本：1.08亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 265,253,242 | 261,520,749.98 | 360,295,801.19 | 336,534,865.63 |
| 应收票据及应收账款 | 183,302,941.53 | 164,480,663.01 | 113,109,996.43 | 145,812,934.5 |
| 其中：应收票据 | 76,298,268.87 | 60,833,459.35 | 56,535,307.14 | 58,284,146.45 |
| 应收账款 | 107,004,672.66 | 103,647,203.66 | 56,574,689.29 | 87,528,788.05 |
| 应收款项融资 | 85,029,800.44 | 85,632,767.44 | 69,592,217.27 | 57,650,245.22 |
| 预付款项 | 16,653,221.75 | 7,080,275.27 | 15,813,280.41 | 4,403,359.17 |
| 其他应收款合计 | 2,894,392.44 | 4,931,408.34 | 2,469,285.69 | 1,694,829.9 |
| 存货 | 87,486,312.81 | 95,111,078.72 | 102,883,703.24 | 123,495,513.43 |
| 其他流动资产 | 29,227,084.78 | 31,924,828.89 | 25,341,510.94 | 21,367,034.76 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 721,990,703.1 | 731,163,266.12 | 757,240,486.53 | 840,523,458.73 |
| 非流动资产: | | | | |
| 其他权益工具投资 | 500,000 | 500,000 | 500,000 | 500,000 |
| 固定资产 | 281,455,321.13 | 289,626,171.33 | 276,321,454.78 | 284,544,095.75 |
| 在建工程 | 584,937,869.19 | 548,027,803.41 | 446,829,306.21 | 363,839,877.73 |
| 无形资产 | 84,036,404.73 | 84,528,767.74 | 85,144,881.58 | 85,777,652.11 |
| 递延所得税资产 | 4,912,100.05 | 5,443,748.79 | 4,160,244.43 | 3,702,523.09 |
| 其他非流动资产 | 35,519,770.96 | 28,447,652.74 | 76,595,074.16 | 76,306,368.97 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 991,361,466.06 | 956,574,144.01 | 889,550,961.16 | 814,670,517.65 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,713,352,169.16 | 1,687,737,410.13 | 1,646,791,447.69 | 1,655,193,976.38 |
| 流动负债: | | | | |
| 短期借款 | 2,010,000 | 1,010,847.22 | 3,012,357.53 | 7,025,349.34 |
| 衍生金融负债 | 45,976.24 | 264,838.83 | - | - |
| 应付票据及应付账款 | 263,713,765.58 | 237,056,629.65 | 213,761,373.29 | 228,006,037.71 |
| 其中：应付票据 | 141,281,547.13 | 105,500,678.72 | 110,699,425.83 | 121,505,314.87 |
| 应付账款 | 122,432,218.45 | 131,555,950.93 | 103,061,947.46 | 106,500,722.84 |
| 合同负债 | 1,980,853.87 | 2,438,520.71 | 2,421,829.06 | 542,219.96 |
| 应付职工薪酬 | 5,167,418 | 13,837,761.71 | 9,905,307.54 | 7,631,595.49 |
| 应交税费 | 3,044,254.33 | 4,001,778.22 | 2,649,081.6 | 3,327,268.83 |
| 其他应付款合计 | 374,635.57 | 427,635.63 | 277,155.77 | 283,146.89 |
| 其他流动负债 | 29,118,658.67 | 32,909,335.93 | 20,356,850.46 | 14,312,028.31 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 305,455,562.26 | 291,947,347.9 | 252,383,955.25 | 261,127,646.53 |
| 非流动负债: | | | | |
| 递延收益 | 24,537,850.63 | 24,976,221.77 | 25,804,385.42 | 21,154,087.59 |
| 递延所得税负债 | 103,546.11 | 53,450.48 | 96,000.43 | 35,038.67 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 24,641,396.74 | 25,029,672.25 | 25,900,385.85 | 21,189,126.26 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 330,096,959 | 316,977,020.15 | 278,284,341.1 | 282,316,772.79 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,000,000 | 108,000,000 | 108,000,000 | 108,000,000 |
| 资本公积 | 744,142,359.37 | 744,142,359.37 | 744,142,359.37 | 744,142,359.37 |
| 专项储备 | 4,399,943.94 | 3,546,479.94 | 3,116,692.44 | 3,852,679.56 |
| 盈余公积 | 54,203,227.31 | 54,203,227.31 | 52,480,774 | 52,480,774 |
| 未分配利润 | 441,155,429.46 | 429,980,147.18 | 427,966,509.43 | 430,885,023.38 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,351,900,960.08 | 1,339,872,213.8 | 1,335,706,335.24 | 1,339,360,836.31 |
| 少数股东权益 | 31,354,250.08 | 30,888,176.18 | 32,800,771.35 | 33,516,367.28 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,383,255,210.16 | 1,370,760,389.98 | 1,368,507,106.59 | 1,372,877,203.59 |
| 负债和股东权益合计 | 1,713,352,169.16 | 1,687,737,410.13 | 1,646,791,447.69 | 1,655,193,976.38 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-30 | 2024-08-29 |
| 审计意见(境内) | | 标准无保留意见 | | |